For the past several years, I’ve been following the news of how India’s pharmaceutical patent laws are gradually changing. What sometimes reads as pure legalese actually has far-reaching implications, because many of the medicines that treat poor people around the world are made here at low cost. But last year, India’s government moved to restrict their dynamic pharmaceutical industry.
I’ve always had it in the back of my mind that I should write a story that pulls everything together: the personalities, legislation, science, business, etc., rolled into one package that explains it all. Well, Erika Check beat me to it in her recent Wired magazine piece. Excellent work!